SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-059366
Filing Date
2024-03-05
Accepted
2024-03-05 16:48:04
Documents
19
Period of Report
2024-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816527d8k.htm   iXBRL 8-K 66151
2 EX-2.1 d816527dex21.htm EX-2.1 682874
3 EX-3.1 d816527dex31.htm EX-3.1 5368
4 EX-10.1 d816527dex101.htm EX-10.1 27654
5 EX-10.2 d816527dex102.htm EX-10.2 29034
6 EX-99.1 d816527dex991.htm EX-99.1 34212
  Complete submission text file 0001193125-24-059366.txt   1180436

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20240303.xsd EX-101.SCH 2499
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20240303_lab.xml EX-101.LAB 19444
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20240303_pre.xml EX-101.PRE 12122
21 EXTRACTED XBRL INSTANCE DOCUMENT d816527d8k_htm.xml XML 4086
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 24721595
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)